Modification of pyrimidine derivatives from antiviral agents to antitumor agents

Hiroyuki Kimura, Takahiro Katoh, Tetsuya Kajimoto, Manabu Node, Masakatsu Hisaki, Yoshikazu Sugimoto, Tetsuo Majima, Yoshimasa Uehara, Takao Yamori

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

2,4-Diaminopyrimidine derivatives, that were originally developed as antiviral agents, were modified to antitumor agents by: i) introducing an amino group at C-5 on the pyrimidine ring, ii) changing the alkyl group and the ring size of the cycloalkyl group on the β-position of the ω- hydroxyalkylamino group, iii) replacing the phenylalkyl group on the cycloalkyl group with the 3,4,5-trimethoxyphenylalkyl group, iv) the esterification of the primary alcohol with diethyl phosphate and v) introducing the thiomethyl group at C-2 on the pyrimidine ring. Among the 21 compounds prepared, 6, which has cyclobutyl at the β-position, exhibited potent activity towards P-388 leukemia. In addition, 14, with methoxyl groups on the phenyl ring and 17, with the thiomethyl group on the pyrimidine ring, showed specific inhibition for the EGFR protein kinase. Moreover, 15 and 16, which carry the diethyl phosphoryl group on the primary alcohol, exhibited inhibitory activity towards P-glycoprotein.

Original languageEnglish
Pages (from-to)91-97
Number of pages7
JournalAnticancer Research
Volume26
Issue number1 A
Publication statusPublished - 2006 Jan
Externally publishedYes

Fingerprint

Antineoplastic Agents
Antiviral Agents
Alcohols
Esterification
P-Glycoprotein
Protein Kinases
Leukemia
pyrimidine
diethyl phosphate
2,4-diaminopyrimidine

Keywords

  • Antitumor agents
  • Antiviral agents
  • Pyrimidine derivatives

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kimura, H., Katoh, T., Kajimoto, T., Node, M., Hisaki, M., Sugimoto, Y., ... Yamori, T. (2006). Modification of pyrimidine derivatives from antiviral agents to antitumor agents. Anticancer Research, 26(1 A), 91-97.

Modification of pyrimidine derivatives from antiviral agents to antitumor agents. / Kimura, Hiroyuki; Katoh, Takahiro; Kajimoto, Tetsuya; Node, Manabu; Hisaki, Masakatsu; Sugimoto, Yoshikazu; Majima, Tetsuo; Uehara, Yoshimasa; Yamori, Takao.

In: Anticancer Research, Vol. 26, No. 1 A, 01.2006, p. 91-97.

Research output: Contribution to journalArticle

Kimura, H, Katoh, T, Kajimoto, T, Node, M, Hisaki, M, Sugimoto, Y, Majima, T, Uehara, Y & Yamori, T 2006, 'Modification of pyrimidine derivatives from antiviral agents to antitumor agents', Anticancer Research, vol. 26, no. 1 A, pp. 91-97.
Kimura H, Katoh T, Kajimoto T, Node M, Hisaki M, Sugimoto Y et al. Modification of pyrimidine derivatives from antiviral agents to antitumor agents. Anticancer Research. 2006 Jan;26(1 A):91-97.
Kimura, Hiroyuki ; Katoh, Takahiro ; Kajimoto, Tetsuya ; Node, Manabu ; Hisaki, Masakatsu ; Sugimoto, Yoshikazu ; Majima, Tetsuo ; Uehara, Yoshimasa ; Yamori, Takao. / Modification of pyrimidine derivatives from antiviral agents to antitumor agents. In: Anticancer Research. 2006 ; Vol. 26, No. 1 A. pp. 91-97.
@article{7a5f8c3cb9b14d67ae5b526243af3725,
title = "Modification of pyrimidine derivatives from antiviral agents to antitumor agents",
abstract = "2,4-Diaminopyrimidine derivatives, that were originally developed as antiviral agents, were modified to antitumor agents by: i) introducing an amino group at C-5 on the pyrimidine ring, ii) changing the alkyl group and the ring size of the cycloalkyl group on the β-position of the ω- hydroxyalkylamino group, iii) replacing the phenylalkyl group on the cycloalkyl group with the 3,4,5-trimethoxyphenylalkyl group, iv) the esterification of the primary alcohol with diethyl phosphate and v) introducing the thiomethyl group at C-2 on the pyrimidine ring. Among the 21 compounds prepared, 6, which has cyclobutyl at the β-position, exhibited potent activity towards P-388 leukemia. In addition, 14, with methoxyl groups on the phenyl ring and 17, with the thiomethyl group on the pyrimidine ring, showed specific inhibition for the EGFR protein kinase. Moreover, 15 and 16, which carry the diethyl phosphoryl group on the primary alcohol, exhibited inhibitory activity towards P-glycoprotein.",
keywords = "Antitumor agents, Antiviral agents, Pyrimidine derivatives",
author = "Hiroyuki Kimura and Takahiro Katoh and Tetsuya Kajimoto and Manabu Node and Masakatsu Hisaki and Yoshikazu Sugimoto and Tetsuo Majima and Yoshimasa Uehara and Takao Yamori",
year = "2006",
month = "1",
language = "English",
volume = "26",
pages = "91--97",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1 A",

}

TY - JOUR

T1 - Modification of pyrimidine derivatives from antiviral agents to antitumor agents

AU - Kimura, Hiroyuki

AU - Katoh, Takahiro

AU - Kajimoto, Tetsuya

AU - Node, Manabu

AU - Hisaki, Masakatsu

AU - Sugimoto, Yoshikazu

AU - Majima, Tetsuo

AU - Uehara, Yoshimasa

AU - Yamori, Takao

PY - 2006/1

Y1 - 2006/1

N2 - 2,4-Diaminopyrimidine derivatives, that were originally developed as antiviral agents, were modified to antitumor agents by: i) introducing an amino group at C-5 on the pyrimidine ring, ii) changing the alkyl group and the ring size of the cycloalkyl group on the β-position of the ω- hydroxyalkylamino group, iii) replacing the phenylalkyl group on the cycloalkyl group with the 3,4,5-trimethoxyphenylalkyl group, iv) the esterification of the primary alcohol with diethyl phosphate and v) introducing the thiomethyl group at C-2 on the pyrimidine ring. Among the 21 compounds prepared, 6, which has cyclobutyl at the β-position, exhibited potent activity towards P-388 leukemia. In addition, 14, with methoxyl groups on the phenyl ring and 17, with the thiomethyl group on the pyrimidine ring, showed specific inhibition for the EGFR protein kinase. Moreover, 15 and 16, which carry the diethyl phosphoryl group on the primary alcohol, exhibited inhibitory activity towards P-glycoprotein.

AB - 2,4-Diaminopyrimidine derivatives, that were originally developed as antiviral agents, were modified to antitumor agents by: i) introducing an amino group at C-5 on the pyrimidine ring, ii) changing the alkyl group and the ring size of the cycloalkyl group on the β-position of the ω- hydroxyalkylamino group, iii) replacing the phenylalkyl group on the cycloalkyl group with the 3,4,5-trimethoxyphenylalkyl group, iv) the esterification of the primary alcohol with diethyl phosphate and v) introducing the thiomethyl group at C-2 on the pyrimidine ring. Among the 21 compounds prepared, 6, which has cyclobutyl at the β-position, exhibited potent activity towards P-388 leukemia. In addition, 14, with methoxyl groups on the phenyl ring and 17, with the thiomethyl group on the pyrimidine ring, showed specific inhibition for the EGFR protein kinase. Moreover, 15 and 16, which carry the diethyl phosphoryl group on the primary alcohol, exhibited inhibitory activity towards P-glycoprotein.

KW - Antitumor agents

KW - Antiviral agents

KW - Pyrimidine derivatives

UR - http://www.scopus.com/inward/record.url?scp=32144437830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32144437830&partnerID=8YFLogxK

M3 - Article

C2 - 16475684

AN - SCOPUS:32144437830

VL - 26

SP - 91

EP - 97

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1 A

ER -